Jerome Stevens Pharmaceuticals is a renowned family-owned and operated pharmaceutical brand specializing in the manufacturing of prescription tablet and capsule formulations. With a rich history dating back to 1979, the company initially focused on producing high-quality vitamin and over-the-counter preparations. In 1987, they successfully transitioned into prescription manufacturing with FDA approval for Cephalexin Monhydrate capsules, USP.

Driven by a commitment to excellence, Jerome Stevens Pharmaceuticals embarked on the development of generic Levothyroxine Sodium tablets, USP, and Digoxin tablets, USP in 1990. Overcoming manufacturing challenges, they emerged as leaders in the industry, offering superior quality products compared to their competitors. Jerome Stevens Pharmaceuticals achieved a major milestone in 2000, as they became the first company to receive FDA approval for the first branded Levothyroxine product, Unithroid®.

Their dedication to quality and safety continues to drive their success, ensuring the production of the safest products on the market. Despite their growth, they remain a family-owned and operated business, infused with pride and satisfaction in the exceptional quality of their pharmaceuticals